SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-091167
Filing Date
2021-03-23
Accepted
2021-03-23 16:06:22
Documents
67
Period of Report
2021-02-24
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d67342d8ka.htm 8-K/A 18718
2 EX-23.1 d67342dex231.htm EX-23.1 7330
3 EX-99.1 d67342dex991.htm EX-99.1 345031
4 EX-99.2 d67342dex992.htm EX-99.2 190625
  Complete submission text file 0001193125-21-091167.txt   4631658

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snss-20210224.xml EX-101.INS 954565
6 XBRL TAXONOMY EXTENSION SCHEMA snss-20210224.xsd EX-101.SCH 45769
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20210224_cal.xml EX-101.CAL 36913
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20210224_def.xml EX-101.DEF 229027
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20210224_lab.xml EX-101.LAB 401811
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20210224_pre.xml EX-101.PRE 337294
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-51531 | Film No.: 21764865
SIC: 2834 Pharmaceutical Preparations